Breast cancer, Secondary cancers
Results
Phase 1
This trial looked at samuraciclib for cancer that had spread to nearby tissue or to another part of the body. This is called advanced cancer.
Some parts of the trial were for people with triple negative breast cancer. This is breast cancer that doesn’t have receptors for:
the hormones oestrogen and progesterone
a protein called HER2
The trial was open for people to join between 2017 and 2022. The team published the results in 2023.
Recruitment start: 14 November 2017
Recruitment end: 4 August 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sacha Howell
Dr Matthew Krebs
Carrick Therapeutics
Last reviewed: 09 Sept 2024
CRUK internal database number: 16181
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
